Citadel Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
3,464,917
+1,847,689
| +114% | +$9.31M | ﹤0.01% | 1045 |
|
|
2025
Q1 | $10.5M | Buy |
1,617,228
+1,345,964
| +496% | +$8.72M | ﹤0.01% | 1225 |
|
|
2024
Q4 | $1.99M | Buy |
271,264
+2,292
| +0.9% | +$16.8K | ﹤0.01% | 2612 |
|
|
2024
Q3 | $2.01M | Sell |
268,972
-481,015
| -64% | -$3.6M | ﹤0.01% | 2497 |
|
|
2024
Q2 | $6.67M | Sell |
749,987
-2,657,845
| -78% | -$23.7M | ﹤0.01% | 1466 |
|
|
2024
Q1 | $34.5M | Buy |
3,407,832
+369,884
| +12% | +$3.75M | 0.01% | 627 |
|
|
2023
Q4 | $30.6M | Buy |
3,037,948
+2,954,409
| +3,537% | +$29.7M | 0.01% | 664 |
|
|
2023
Q3 | $783K | Buy |
83,539
+19,568
| +31% | +$183K | ﹤0.01% | 3289 |
|
|
2023
Q2 | $1.57M | Sell |
63,971
-267,822
| -81% | -$6.57M | ﹤0.01% | 2622 |
|
|
2023
Q1 | $7.72M | Buy |
331,793
+303,587
| +1,076% | +$7.06M | ﹤0.01% | 1484 |
|
|
2022
Q4 | $714K | Sell |
28,206
-93,754
| -77% | -$2.37M | ﹤0.01% | 3524 |
|
|
2022
Q3 | $2.35M | Buy |
+121,960
| New | +$2.35M | ﹤0.01% | 2581 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6962 |
|
|
2022
Q1 | – | Sell |
-590,876
| Closed | -$24.7M | – | 7172 |
|
|
2021
Q4 | $24.7M | Buy |
590,876
+451,777
| +325% | +$18.9M | 0.01% | 811 |
|
|
2021
Q3 | $6.05M | Buy |
139,099
+108,342
| +352% | +$4.71M | ﹤0.01% | 1881 |
|
|
2021
Q2 | $1.45M | Buy |
30,757
+17,612
| +134% | +$833K | ﹤0.01% | 3587 |
|
|
2021
Q1 | $674K | Sell |
13,145
-11,341
| -46% | -$582K | ﹤0.01% | 4308 |
|
|
2020
Q4 | $656K | Sell |
24,486
-46,153
| -65% | -$1.24M | ﹤0.01% | 3633 |
|
|
2020
Q3 | $2.43M | Sell |
70,639
-93,890
| -57% | -$3.22M | ﹤0.01% | 2099 |
|
|
2020
Q2 | $6.74M | Buy |
+164,529
| New | +$6.74M | ﹤0.01% | 1319 |
|
|
2020
Q1 | – | Sell |
-19,297
| Closed | -$243K | – | 5349 |
|
|
2019
Q4 | $243K | Buy |
+19,297
| New | +$243K | ﹤0.01% | 4019 |
|